
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development
Anaïs M. Quéméner, Maria Laura Centomo, Scott L. Sax, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 536-536
Open Access | Times Cited: 65
Anaïs M. Quéméner, Maria Laura Centomo, Scott L. Sax, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 536-536
Open Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Shanna Qian, Wei Zhong, Wanting Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 457
Shanna Qian, Wei Zhong, Wanting Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 457
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 50
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 50
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Suxiang Chen, Saumya Nishanga Heendeniya, Bao T. Le, et al.
BioDrugs (2024) Vol. 38, Iss. 2, pp. 177-203
Open Access | Times Cited: 25
Suxiang Chen, Saumya Nishanga Heendeniya, Bao T. Le, et al.
BioDrugs (2024) Vol. 38, Iss. 2, pp. 177-203
Open Access | Times Cited: 25
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 18
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 18
Unwinding circular RNA’s role in inflammatory pulmonary diseases
Asif Ahmad Bhat, Gaurav Gupta, Ahsas Goyal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2567-2588
Closed Access | Times Cited: 40
Asif Ahmad Bhat, Gaurav Gupta, Ahsas Goyal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2567-2588
Closed Access | Times Cited: 40
The potential role of miRNAs in the pathogenesis of cardiovascular diseases – A focus on signaling pathways interplay
Emad Gamil Khidr, Ahmed I. Abulsoud, Ayman A. Doghish, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154624-154624
Closed Access | Times Cited: 38
Emad Gamil Khidr, Ahmed I. Abulsoud, Ayman A. Doghish, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154624-154624
Closed Access | Times Cited: 38
Versatility of Liposomes for Antisense Oligonucleotide Delivery: A Special Focus on Various Therapeutic Areas
Raghav Gupta, Sagar Salave, Dhwani Rana, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1435-1435
Open Access | Times Cited: 24
Raghav Gupta, Sagar Salave, Dhwani Rana, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1435-1435
Open Access | Times Cited: 24
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
Anamaria Jurcău, Maria Carolina Jurcău
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1895-1895
Open Access | Times Cited: 29
Anamaria Jurcău, Maria Carolina Jurcău
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1895-1895
Open Access | Times Cited: 29
Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs
Damiano Bartolucci, Andrea Pession, Patrizia Hrelia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 27
Damiano Bartolucci, Andrea Pession, Patrizia Hrelia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 27
MicroRNAs in Cancer and Cardiovascular Disease
Mirolyuba Ilieva, Riccardo Panella, Shizuka Uchida
Cells (2022) Vol. 11, Iss. 22, pp. 3551-3551
Open Access | Times Cited: 24
Mirolyuba Ilieva, Riccardo Panella, Shizuka Uchida
Cells (2022) Vol. 11, Iss. 22, pp. 3551-3551
Open Access | Times Cited: 24
Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress
Bogdan Dume, Emilia Licărete, Manuela Banciu
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102256-102256
Open Access | Times Cited: 6
Bogdan Dume, Emilia Licărete, Manuela Banciu
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102256-102256
Open Access | Times Cited: 6
Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis
Shuo Zhang, Yunxiu Xia, Weiwei Chen, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 4
Shuo Zhang, Yunxiu Xia, Weiwei Chen, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 4
Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics
Benjamin Ayodipupo Babalola, Oluwamayowa S. Akinsuyi, Elizabeth Oreoluwa Folajimi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115099-115099
Open Access | Times Cited: 10
Benjamin Ayodipupo Babalola, Oluwamayowa S. Akinsuyi, Elizabeth Oreoluwa Folajimi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115099-115099
Open Access | Times Cited: 10
The Role of microRNA-22 in Metabolism
Simone Tomasini, Paolo Vigo, Francesco Margiotta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 782-782
Open Access
Simone Tomasini, Paolo Vigo, Francesco Margiotta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 782-782
Open Access
Analysis of Exon Skipping Applicability for Dysferlinopathies
Jamie Leckie, Samantha Rodriguez, Martin Krahn, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 177-177
Open Access
Jamie Leckie, Samantha Rodriguez, Martin Krahn, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 177-177
Open Access
Synthesis and Application of 4′-C-[(N-alkyl)aminoethyl]thymidine Analogs for Optimizing Oligonucleotide Properties
Kanji Fujiki, Yuri Kakisawa, Elsayed M. Mahmoud, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 581-581
Open Access
Kanji Fujiki, Yuri Kakisawa, Elsayed M. Mahmoud, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 581-581
Open Access
Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management
Bhargav Shreevatsa, Anil Belur Nagaraj, Chandan Dharmashekar, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Bhargav Shreevatsa, Anil Belur Nagaraj, Chandan Dharmashekar, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
Heba M. Mansour, Aiman S. El‐Khatib
European Journal of Pharmacology (2025), pp. 177529-177529
Closed Access
Heba M. Mansour, Aiman S. El‐Khatib
European Journal of Pharmacology (2025), pp. 177529-177529
Closed Access
Advances in reparative materials for infectious bone defects and their applications in maxillofacial regions
Ziyi Han, Jingdi Xiong, Xiaohan Jin, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 4, pp. 842-871
Closed Access | Times Cited: 9
Ziyi Han, Jingdi Xiong, Xiaohan Jin, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 4, pp. 842-871
Closed Access | Times Cited: 9
RNA structure in alternative splicing regulation: from mechanism to therapy
Nengcheng Bao, Zhechao Wang, Jiayan Fu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 3
Nengcheng Bao, Zhechao Wang, Jiayan Fu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 3
Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections
Shizhou Wu, Binjie Wu, Yunjie Liu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 14
Shizhou Wu, Binjie Wu, Yunjie Liu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 14
Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides
Damian Kaniowski, Katarzyna Kulik, Justyna Suwara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12190-12190
Open Access | Times Cited: 13
Damian Kaniowski, Katarzyna Kulik, Justyna Suwara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12190-12190
Open Access | Times Cited: 13
MicroRNA targeting: A novel therapeutic intervention for ovarian cancer
Elmira Roshani Asl, Sajed Sarabandi, Behrouz Shademan, et al.
Biochemistry and Biophysics Reports (2023) Vol. 35, pp. 101519-101519
Open Access | Times Cited: 8
Elmira Roshani Asl, Sajed Sarabandi, Behrouz Shademan, et al.
Biochemistry and Biophysics Reports (2023) Vol. 35, pp. 101519-101519
Open Access | Times Cited: 8
Cell-permeable peptide nucleic acid antisense oligonucleotide platform targeting human betacoronaviruses
Soree Park, Seong Ho Kim, Mehrangiz Dezhbord, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Soree Park, Seong Ho Kim, Mehrangiz Dezhbord, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application
Bao T. Le, Suxiang Chen, Rakesh N. Veedu
ACS Omega (2023) Vol. 8, Iss. 51, pp. 48650-48661
Open Access | Times Cited: 8
Bao T. Le, Suxiang Chen, Rakesh N. Veedu
ACS Omega (2023) Vol. 8, Iss. 51, pp. 48650-48661
Open Access | Times Cited: 8